Search Results

You searched for : Merck

	Indiaâ€™s first indigenously developed vaccine against cervical cancer will hit the market soon Indiaâ€™s first indigenously developed human papillomavirus (HPV) vaccine will be soon administered to women in near future. The research and development related to vaccines ... Sep 02
	Biomarker startup Koneksa gains $45 million Digital biomarker startup Koneksa has raised $45 million in their Series C funding round.... Feb 08
	BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in Oncology Corporate News Updates; Pharma Feb 3rd 2022... Feb 03
	HexaHealth and Indiaâ€™s in-patient care segment Out of the $130 billion spent on healthcare, 60% is spent on in-patient care across private providers alone. Despite its importance and size, the ... Jan 19
	Transcarent raises $200M in Series C funding California-based healthcare company, Transcarent, raised $200 million in their Series C fund round by Kinnevik and Human Capital. ... Jan 12
	ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel ... Nov 03
	Evaxion Biotech announces Clinical Collaboration to evaluate Keytruda in melanoma patients Latest news updates... Oct 26
	Merck launches the cosmetic active ingredient RonaCare to strengthen the skin's resilience Latest pharma updates... Oct 12
	Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106 Latest Pharma Update... Aug 23
	Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus.... Jul 17
	BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in Oncology Pharma News Update July 8... Jul 09
	Alzheimer's Disease Fast Facts Facts about the Alzheimer's disease... Jul 08
	LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer... Jun 24
	Merck to Participate in the Guggenheim Biopharma Strategy Series Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series... Jun 19
	Merck Announces Supply Agreement with U.S. Government for Molnupiravir ... Jun 09
	Merck Announces Positive Topline Results from PNEU-DIRECTION (V114-027) and PNEU-PLAN (V114-024) Phase 3 Pediatric Studies for V114, Merckâ€™s Investigational... May 22
	M2GEN announces new collaboration with Merck to advance Cancer therapies Another pharma collaboration for the advancement of cancer therapies ... Mar 22
	Debiopharm grants exclusive license to Merck for Xevinapant This worldwide exclusive license to Merck KGaA, Darmstadt, Germany for the development and commercialization of Xevinapant ... Mar 03
	Lupin Launches Posaconazole Delayed-Release Tablets Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA... Feb 17
	Philips and Merck partner to advance personalized fertility treatment Royal Philips, a global leader in health technology, today announced a multi-year partnership with Merck, a leading science and technology company, to develop clinical-... Jan 15
	U.S. FDA Accepts for Priority Review the Biologics License Application for V114 Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merckâ€™s investigational 15-valent pneumococcal conjugate vaccine, for ... Jan 12
	Propanc Biopharma Advances POP1 Joint Research and Drug Discovery Program The drugs discovery program is for servicing the US$111.2B global Metastatic Cancer market... Dec 31
	LYNPARZA (olaparib) Receives Three New Approvals in Japan LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer.... Dec 28
	A2 Biotherapeutics enters into collaboration agreement With Merck ; cell therapy for solid tumor Cancers ... Dec 26
	Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19 ... Dec 23
25 Matching result(s) found!

-Advertisements-

Trending Now
	EV Conference 24---Charging Up for e-mobility Minister Ponnam Prabhakar and Jayesh Ranjan among others to graceJune 14, 2024
	Are we on track to end AIDS, end viral hepatitis and end STIs by 2030?June 14, 2024
	HR Conclave Focusing on Future-Forward Engineering where Engineering and Management students meet their future employees, thus exposing students to real-world HR challenges and innovative solutionsJune 14, 2024
	MAGGI Empowers 10 Women to Bring their Entrepreneurial dreams to lifeJune 13, 2024
	FTCCI announced its Annual Excellence Awards and invites entries, last date is 20th June 2024June 13, 2024
	Bird Flu Cases by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.June 13, 2024
	Sova Health's $1 Million Seed Funding to Drive Gut Health InnovationJune 13, 2024
	The Vital Role of Early Detection: Kevin Jonas on Battling Skin CancerJune 13, 2024
	Zumutor Biologics Advances Cancer Care with Novel Immunotherapy ZM008: A First-in-Class Anti LLT1 AntibodyJune 13, 2024
	HP Ghosh Hospital Unveils Innovative "Chest Tree" June 12, 2024
	Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, IndiaJune 12, 2024
	From the frontlines: Homeless person won over alcoholism, survived floods and defeated TBJune 12, 2024
	The Role of Hormones in Obesity: Why Men and Women Gain Weight DifferentlyJune 12, 2024
	Silent Killer: How a Young Mother’s Vision Loss Led to a Lung Cancer DiagnosisJune 12, 2024
	TruAlt Bioenergy’s subsidiary, Leafiniti Bioenergy supplies over 1000 tons of Compressed Biogas to AG&P Pratham in just 5 monthsJune 11, 2024
	Southeast Asia's Most Advanced Luxury Postpartum Centre Re'Joy Suites Opens in SingaporeJune 11, 2024
	Poor Muscle Health in Obesity Can be A Major Risk Factor for Early DeathJune 11, 2024
	Machine Learning Uncovers How Organ Ageing Impacts Health and LongevityJune 11, 2024
	Why Education is Essential for Health and LongevityJune 11, 2024
	New Study Reveals Antidepressant Withdrawal Symptoms Less Common but Still SignificantJune 10, 2024

Search Results

Indiaâ€™s first indigenously developed vaccine against cervical cancer will hit the market soon

Biomarker startup Koneksa gains $45 million

BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in Oncology

HexaHealth and Indiaâ€™s in-patient care segment

Transcarent raises $200M in Series C funding

ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel

Evaxion Biotech announces Clinical Collaboration to evaluate Keytruda in melanoma patients

Merck launches the cosmetic active ingredient RonaCare to strengthen the skin's resilience

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106

Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older

BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in Oncology

Alzheimer's Disease Fast Facts

LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Merck to Participate in the Guggenheim Biopharma Strategy Series

Merck Announces Supply Agreement with U.S. Government for Molnupiravir

Merck Announces Positive Topline Results from PNEU-DIRECTION (V114-027) and PNEU-PLAN (V114-024)

M2GEN announces new collaboration with Merck to advance Cancer therapies

Debiopharm grants exclusive license to Merck for Xevinapant

Lupin Launches Posaconazole Delayed-Release Tablets

Philips and Merck partner to advance personalized fertility treatment

U.S. FDA Accepts for Priority Review the Biologics License Application for V114

Propanc Biopharma Advances POP1 Joint Research and Drug Discovery Program

LYNPARZA (olaparib) Receives Three New Approvals in Japan

A2 Biotherapeutics enters into collaboration agreement With Merck ; cell therapy for solid tumor Cancers

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19

Trending Now